Incyte Corporation (LON:0J9P)
72.50
+1.67 (2.36%)
At close: Feb 21, 2025
Incyte Revenue
In the year 2024, Incyte had annual revenue of $4.24B USD with 14.76% growth. Incyte had revenue of $1.18B in the quarter ending December 31, 2024, with 16.32% growth.
Revenue
$4.24B
Revenue Growth
+14.76%
P/S Ratio
n/a
Revenue / Employee
$1.62M
Employees
2,617
Market Cap
11.04B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.24B | 545.57M | 14.76% |
Dec 31, 2023 | 3.70B | 301.01M | 8.87% |
Dec 31, 2022 | 3.39B | 408.37M | 13.67% |
Dec 31, 2021 | 2.99B | 319.57M | 11.98% |
Dec 31, 2020 | 2.67B | 507.94M | 23.53% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
Hikma Pharmaceuticals | 2.39B |
ConvaTec Group | 1.74B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Incyte News
- 3 days ago - Incyte and Genesis to collaborate on developing small molecule medicines using AI research - Seeking Alpha
- 3 days ago - Incyte and Genesis Therapeutics Announce Strategic AI-focused Research Collaboration - Business Wire
- 4 days ago - Incyte Stock Sees Relative Strength Rating Rise To 71 - Investor's Business Daily
- 5 days ago - Incyte to Present at Upcoming Investor Conferences - Benzinga
- 5 days ago - Incyte to Present at Upcoming Investor Conferences - Business Wire
- 9 days ago - Incyte jumps amid takeover speculation - Seeking Alpha
- 11 days ago - Reevaluating Incyte Corporation After Earnings (Technical Analysis) - Seeking Alpha
- 12 days ago - Incyte: Q4 Earnings Outline Multiple Drug Launches In 2025 - Seeking Alpha